Clarification statement regarding AXA's holdings in AstraZeneca PLC
AstraZeneca PLC (the 'Company') notes that a number of media sources have reported an aggregate interest held by AXA S.A. and its subsidiary undertakings (the 'AXA Group') in the ordinary share capital of the Company, based on out of date information.
Consequently, the Company wishes to clarify the current holdings of AXA S.A. and its subsidiary undertakings in the ordinary share capital of the Company.
Based on the issued share capital of the Company with voting rights of 1,262,502,850 ordinary shares of US$0.25 announced on 2 June 2014, the disaggregated interests of the AXA Group are as set out below. Accordingly, as at 11 June 2014, neither AXA S.A. itself nor any of its subsidiary undertakings held a notifiable interest under the UK Financial Conduct Authority's Disclosure and Transparency Rules.
|
Number of shares with voting rights |
Percentage of voting rights |
AXA Investment Managers S.A. |
11,685,089 |
0.93% |
AXA S.A. |
759,758 |
0.06% |
AllianceBernstein |
989,364 |
0.08% |
A C N Kemp
Company Secretary
13 June 2014
